Technology | Lung Imaging | October 05, 2018

Platform creates augmented reality to see fluoroscopically invisible lung lesions

Body Vision Medical Announces Release of LungVision

October 5, 2018 — Body Vision Medical, a medical device company specializing in lung cancer diagnostics, announced the launch of its LungVision platform. The platform will be presented at the CHEST conference, Oct. 7-10 in San Antonio, Texas.

"Body Vision provides a great tool that has changed the way we approached peripheral nodules. Its unique technology creates augmented reality with the ability to see fluoroscopically invisible lesions and the pathways under the live fluoro, while tracking a patient breathing," said D. Kyle Hogarth, M.D., FCCP, president of the Society for Advanced Bronchoscopy, associate professor of medicine, director of bronchoscopy at the University of Chicago. "Once the technology has guided us to the lesion, we confirm the lesion's relationship to the airway with radial-EBUS [endobronchial ultrasound]. We then use our off-the-shelf biopsy instruments via the LungVision catheter. The augmented fluoro image, integrated with the radial EBUS images, allows us to obtain tissue samples with continuous real-time confirmation of location. The beauty of it all is how simple and elegant the technology is."

Body Vision CEO Dorian Averbuch said the product targets small pulmonary nodules that, if diagnosed early, can be resected to cure lung cancer. The technology provides step-by-step guidance through planning, navigation and lesion localization during biopsy.

The clinical experience with the LungVision platform will be featured through the following panel presentations during the CHEST conference at San Antonio, TX:

  • Sun. Oct. 7
    • Krish Bhadra, M.D., Novel Augmented Fluoroscopic Imaging Platform Accuracy Assessment during Navigation Bronchoscopy in Simultaneous Comparison with Cone Beam CT and Radial EBUS
    • D. Kyle Hogarth, M.D., FCCP, A Novel Endobrachial Fluoroscopic Navigation and Localization System: a summary of a multi-center LungVision Trial
  • Tue., Oct. 9
    • Patrick E. Whitten, M.D., FCCP, Augmented Endobronchial Fluoroscopic Navigation and Localization System: Integration of Multimodalities and Biopsy Tools to Increase Diagnostic Yield

For more information: www.bodyvisionmedical.com


Related Content

News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | FDA

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Time February 26, 2026
arrow
News | Interventional Radiology

Feb.12, 2026 — The University of South Florida’s Center for Advanced Medical Learning and Simulation (CAMLS), part of ...

Time February 23, 2026
arrow
News | Digital Pathology

Feb. 11, 2026 — Leica Biosystems has announced the global launch of the Leica CM1950 Cryostat with DualEcoTec Cooling ...

Time February 11, 2026
arrow
News | Lung Imaging

Feb. 3, 2026 — RevealDx, a leader in the characterization of lung nodules, recently announced FDA clearance of RevealAI ...

Time February 04, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Point-of-Care Ultrasound (POCUS)

Jan. 22, 2026 — Qure.ai has received a grant from the Gates Foundation to develop a large open-source multi-modal ...

Time January 23, 2026
arrow
News | Radiation Oncology

Jan. 8, 2026 — RefleXion Medical, an external-beam theranostic oncology company, has announced the U.S. Food and Drug ...

Time January 13, 2026
arrow
News | PACS

Dec. 1, 2025 — At RSNA 2025, Raidium is introducing its new AI-native PACS Viewer powered by Curia, the first Foundation ...

Time December 01, 2025
arrow
News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
Subscribe Now